Heidelberger & Partners helps life sciences firms turn compliance into a strategic advantage. They enable strong compliance and governance, confident decisions with a practical, business-focused approach, offering IPO readiness (non-financial compliance), board governance, and interim CCO support.
Products, services, technology
Helping organisations prepare for U.S. public markets by strengthening non-financial compliance and building robust programmes. They enhance board effectiveness and governance to meet investor expectations, and provide hands-on compliance leadership to deliver results without full-time hires.
Cooperation possibilities
IPO readiness support for U.S. public markets, board and governance advisory, and interim or fractional Chief Compliance Officer services. Flexible, hands-on collaboration tailored to organisational needs.
- https://heidelbergerpartners.com/
- +41 79 266 69 74
- Send an email
- Martina Heidelberger
Some insights
We make the world better by promoting ethical leadership and helping life sciences leaders balance commercial goals with the needs of vulnerable patients. We make compliance a strategic, independent force for better decisions, stronger trust and better outcomes for patients and society.
We are proud to combine global industry experience, strategic thinking + a deep understanding of human realities. We recognise commercial pressures + temptations, while believing business success and patient ethics can coexist. We help leaders navigate complexity with clarity, integrity and empathy.
Our team combines results-driven strategic and management expertise with strong cross-functional partnership, communication and negotiation skills. We excel at navigating complex dilemmas and aligning diverse interests in fast-paced, intercultural environments with clarity and pragmatism.
Our team combines results-driven strategic and management expertise with strong communication, negotiation and cross-functional partnership skills. We navigate complex dilemmas, align diverse interests, perspectives and expectations with clarity, pragmatism in fast-paced, intercultural environments.
Help us identify biotech companies where our expertise in governance, compliance and ethical leadership can create impact. Insights into sector practices and introductions to open, learning-oriented boards and leaders would help us better understand needs and create value.
We seek connections with biotech/life sciences companies, investors and boards at all stages who value strategic compliance, ethical leadership and strong governance. We are open to governance mandates and to partnerships that help organisations navigate complexity and create sustainable value.
